NGM Stock Price History and Quote Analysis Insights for Investors
NGM Biopharmaceuticals, Inc.
Stock Price Today
NGM Biopharmaceuticals, Inc. (NGM) stock declined over -1.28%, trading at $1.54 on NASDAQ, down from the previous close of $1.56. The stock opened at $1.56, fluctuating between $1.54 and $1.57 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase IIb clinical trials for use in the treatment of type 2 diabetes and NASH. Its products under development also comprise NGM120, an antagonist antibody that binds GFRAL that is in Phase I/II clinical trials; NGM621, an immunoglobulin 1 monoclonal antibody in Phase II clinical trials for the treatment of geographic atrophy; NGM707, an immunoglobulin-like transcript 2/ immunoglobulin-like transcript 4 dual antagonist monoclonal antibody that is in Phase I/II clinical trials for the treatment of patients with advanced solid tumors; and NGM831 and NGM438 for the treatment of advanced solid tumors. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp.; and a collaboration agreement with Merck & Co., Inc. to focus primarily on the development of novel medicines for unmet patient needs in retinal and CVM diseases, including heart failure. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.
Company Information
| Employees | 138 |
| Beta | 1.26 |
| Sales or Revenue | $4.42M |
| 5Y Sales Change% | -0.968% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) stock price is $1.54 in the last trading session. During the trading session, NGM stock reached the peak price of $1.57 while $1.54 was the lowest point it dropped to. The percentage change in NGM stock occurred in the recent session was -1.28% while the dollar amount for the price change in NGM stock was -$0.02.
The NASDAQ listed NGM is part of Biotechnology industry that operates in the broader Healthcare sector. NGM Biopharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Valerie L. Pierce J.D.
Senior Vice President, Gen. Counsel, Sec. & Chief Compliance Officer
Diana Peng Bockus
Head of Bus. Devel.
Dr. Jin-Long Chen Ph.D.
Founder, Chief Scientific Officer & Director
Mr. Brian Muma
Vice President of People Operations
Dr. Hsiao Dee Lieu
Chief Medical Officer & Senior Vice President
Dr. Alex DePaoli
Chief Translational Officer & Senior Vice President
Arthur Hsu Ph.D.
Senior Director & Head of Biology
Jessica Ferreyra Ph.D.
Chief of Staff, Research
Brian Schoelkopf
Senior Director of Corporation Fin. & IR
Dr. David J. Woodhouse Ph.D.
Chief Executive Officer & Director
Ms. Siobhan Nolan Mangini
Pres & Chief Financial Officer
Dr. Hsiao Dee Lieu F.A.C.C., M.D.
Chief Medical Officer & Executive Vice President
Mr. Daniel Kaplan Ph.D.
Chief Scientific Officer
Anthony Kuhlmann Ph.D.
Head of Intellectual Property
Mr. William J. Rieflin J.D.
Executive Chairman of Directors
NGM's closing price is 156.58% higher than its 52-week low of $0.60 where as its distance from 52-week high of $4.69 is -67.16%.
Number of NGM employees currently stands at 138.
Official Website of NGM is: https://www.ngmbio.com
NGM could be contacted at phone 650 243 5555 and can also be accessed through its website. NGM operates from 333 Oyster Point Boulevard, South San Francisco, CA 94080, United States.
NGM stock volume for the day was 2.21M shares. The average number of NGM shares traded daily for last 3 months was 1.07M.
The market value of NGM currently stands at $128.53M with its latest stock price at $1.54 and 83.46M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com